Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk

References

• SinghD, AgustiA, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-201930846476
   PubMed Web of Science ®Google Scholar
• World Health Organization. COPD: definition. Chronic respiratory diseases; 2019 Available from: https://www.who.int/respiratory/copd/definition/en/. Accessed 1113, 2019..
   Google Scholar
• SmithMC, WrobelJP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD25210449
   PubMed Web of Science ®Google Scholar
• MurrayCJ, AtkinsonC, BhallaK, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608. doi:10.1001/jama.2013.1380523842577
   PubMed Web of Science ®Google Scholar
• GuarascioAJ, RaySM, FinchCK, SelfTH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235–245. doi:10.2147/CEOR.S3432123818799
   PubMedGoogle Scholar
• HuberMB, WackerME, VogelmeierCF, LeidlR. Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review. PLoS One. 2015;10(4):e0123292. doi:10.1371/journal.pone.012329225875204
   PubMed Web of Science ®Google Scholar
• WestneyG, ForemanMG, XuJ, Henriques KingM, FlenaughE, RustG. Impact of comorbidities among medicaid enrollees with chronic obstructive pulmonary disease, United States, 2009. Prev Chronic Dis. 2017;14:E31. doi:10.5888/pcd14.16033328409741
   PubMed Web of Science ®Google Scholar
• YinHL, YinSQ, LinQY, XuY, XuHW, LiuT. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine. 2017;96(19):e6836. doi:10.1097/MD.000000000000683628489768
   PubMed Web of Science ®Google Scholar
• AnecchinoC, RossiE, FanizzaC, De RosaM, TognoniG, RomeroM. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis. 2007;2(4):567–574.18268930
   PubMedGoogle Scholar
• SchwabP, DhamaneAD, HopsonSD, et al. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly medicare population. Int J Chron Obstruct Pulmon Dis. 2017;12:735–744. doi:10.2147/COPD.S11225628260880
   PubMed Web of Science ®Google Scholar
• KaszubaE, OdebergH, RastamL, HallingA. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study. BMC Fam Pract. 2018;19(1):178. doi:10.1186/s12875-018-0865-830474547
   PubMed Web of Science ®Google Scholar
• PressVG, KonetzkaRT, WhiteSR. Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program. Curr Opin Pulm Med. 2018;24(2):138–146. doi:10.1097/MCP.000000000000045429210750
   PubMed Web of Science ®Google Scholar
• JiangX, XiaoH, SegalR, MobleyWC, ParkH. Trends in readmission rates, hospital charges, and mortality for patients with chronic obstructive pulmonary disease (COPD) in Florida from 2009 to 2014. Clin Ther. 2018;40(4):613–626.e611. doi:10.1016/j.clinthera.2018.03.00629609879
   PubMed Web of Science ®Google Scholar
• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• HillasG, PerlikosF, TsiligianniI, TzanakisN. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.S5447325609943
   PubMed Web of Science ®Google Scholar
• SimmeringJE, PolgreenLA, ComellasAP, CavanaughJE, PolgreenPM. Identifying patients with COPD at high risk of readmission. Chronic Obstr Pulm Dis. 2016;3(4):729. doi:10.15326/jcopdf.3.4.2016.013628848899
   PubMedGoogle Scholar
• SharifR, ParekhTM, PiersonKS, KuoYF, SharmaG. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5):685–694. doi:10.1513/AnnalsATS.201310-358OC24784958
   PubMedGoogle Scholar
• RobertsMH, Clerisme-BeatyE, KozmaCM, ParisA, SlatonT, MapelDW. A retrospective analysis to identify predictors of COPD-related rehospitalization. BMC Pulm Med. 2016;16(1):68. doi:10.1186/s12890-016-0231-327130455
   PubMed Web of Science ®Google Scholar
• JacobsDM, NoyesK, ZhaoJ, et al. Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the nationwide readmissions database. Ann Am Thorac Soc. 2018;15(7):837–845. doi:10.1513/AnnalsATS.201712-913OC29611719
   PubMed Web of Science ®Google Scholar
• ShahT, PressVG, Huisingh-ScheetzM, WhiteSR. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150(4):916–926. doi:10.1016/j.chest.2016.05.00227167208
   PubMed Web of Science ®Google Scholar
• KilicH, KokturkN, SariG, CakirM. Do females behave differently in COPD exacerbation? Int J Chron Obstruct Pulmon Dis. 2015;10:823–830. doi:10.2147/COPD.S7895225977604
   PubMed Web of Science ®Google Scholar
• HCUP State Inpatient Databases (SID). Healthcare cost and utilization project (HCUP); 2013 Available from: www.hcup-us.ahrq.gov/sidoverview.jsp. Accessed 87, 2019.
   Google Scholar
• LehrkeM, MarxN. Diabetes mellitus and heart failure. Am J Cardiol. 2017;120(1s):S37–S47. doi:10.1016/j.amjcard.2017.05.01428606342
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Prevention Quality Indicators technical specifications: version 6; 2016 Available from: https://www.qualityindicators.ahrq.gov/Archive/PQI_TechSpec_ICD09_v60.aspx. Accessed 86, 2019..
   Google Scholar
• ChalmersJD. Bronchiectasis and COPD overlap: a case of mistaken identity? Chest. 2017;151(6):1204–1206. doi:10.1016/j.chest.2016.12.02728599926
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Prevention quality indicator 05 (PQI 05) chronic obstructive pulmonary disease (COPD) or asthma in older adults admission rate; 2016 Available from: https://www.qualityindicators.ahrq.gov/Downloads/Modules/PQI/V60-ICD09/TechSpecs/PQI_05_Chronic_Obstructive_Pulmonary_Disease_(COPD)_or_Asthma_in_Older_Adults_Admission_Rate.pdf. Accessed 1126, 2019.
   Google Scholar
• ElixhauserA, SteinerC, HarrisDR, CoffeyRM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. doi:10.1097/00005650-199801000-000049431328
   PubMed Web of Science ®Google Scholar
• QuanH, SundararajanV, HalfonP, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.8316224307
   PubMed Web of Science ®Google Scholar
• GreulichT, WeistBJD, KoczullaAR, et al. Prevalence of comorbidities in COPD patients by disease severity in a German population. Respir Med. 2017;132:132–138. doi:10.1016/j.rmed.2017.10.00729229085
   PubMed Web of Science ®Google Scholar
• GotoT, FaridiMK, GiboK, et al. Trends in 30-day readmission rates after COPD hospitalization, 2006–2012. Respir Med. 2017;130:92–97. doi:10.1016/j.rmed.2017.07.05829206640
   PubMed Web of Science ®Google Scholar
• DivoM, CoteC, de TorresJP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC22561964
   PubMed Web of Science ®Google Scholar
• BennettKJ, ProbstJC, BullardJC, CrouchE. The importance of rural hospitals: transfers and 30-day readmissions among rural residents and patients presenting at rural hospitals. Popul Health Manag. 2019;22(2):120–126. doi:10.1089/pop.2018.005030048193
   PubMed Web of Science ®Google Scholar
• DuggalR, ZhangY, DianaML. The association between hospital ACO participation and readmission rates. J Healthc Manag. 2018;63(5):e100–e114. doi:10.1097/JHM-D-16-0004530180036
   PubMed Web of Science ®Google Scholar
• ChukmaitovA, HarlessDW, BazzoliGJ, MuhlesteinDB. Preventable hospital admissions and 30-day all-cause readmissions: does hospital participation in accountable care organizations improve quality of care? Am J Med Qual. 2019;34(1):14–22. doi:10.1177/106286061877878629848000
   PubMed Web of Science ®Google Scholar
• ShresthaPL, ShresthaPA, VivoRP. Epidemiology of comorbidities in patients with hypertension. Curr Opin Cardiol. 2016;31(4):376–380. doi:10.1097/HCO.000000000000029827137759
   PubMed Web of Science ®Google Scholar
• AggarwalAK, SujenthiranA, LewisD, et al. Impact of patient choice and hospital competition on patient outcomes after prostate cancer surgery: a national population-based study. Cancer. 2019;125:1898–1907. doi:10.1002/cncr.3198730707779
   PubMed Web of Science ®Google Scholar
• RobertsCM, StoneRA, LoweD, PurseyNA, BuckinghamRJ. Co-morbidities and 90-day outcomes in hospitalized COPD exacerbations. Copd. 2011;8(5):354–361. doi:10.3109/15412555.2011.60036221864116
   PubMedGoogle Scholar
• AnsariS, HosseinzadehH, DennisS, ZwarN. Patients’ perspectives on the impact of a new COPD diagnosis in the face of multimorbidity: a qualitative study. NPJ Prim Care Respir Med. 2014;24:14036. doi:10.1038/npjpcrm.2014.3625119845
   PubMed Web of Science ®Google Scholar
• GlaserS, KrugerS, MerkelM, BramlageP, HerthFJ. Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature. Respiration. 2015;89(3):253–264. doi:10.1159/00036986325677307
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Reducing chronic obstructive pulmonary disease hospital readmissions. An official American Thoracic Society Workshop ReportMedicare C for Baltimore. MS 7500 SB, USA. Readmissions-Reduction-Program; 2016 Available from: https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. Accessed 87, 2019.
   Google Scholar
• PressVG, AuDH, BourbeauJ, et al. Reducing chronic obstructive pulmonary disease hospital readmissions. An Official American Thoracic society workshop report. Ann Am Thorac Soc. 2019;16(2):161–170. doi:10.1513/AnnalsATS.201811-755WS30707066
   PubMed Web of Science ®Google Scholar
• HanMK, PostmaD, ManninoDM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176(12):1179–1184. doi:10.1164/rccm.200704-553CC17673696
   PubMed Web of Science ®Google Scholar
• BashirB, SchneiderD, NaglakMC, ChurillaTM, AdelsbergerM. Evaluation of prediction strategy and care coordination for COPD readmissions. Hosp Pract (1995). 2016;44(3):123–128. doi:10.1080/21548331.2016.121047227391991
   PubMedGoogle Scholar
• Cerezo LajasA, Gutierrez GonzalezE, Llorente ParradoC, Puente MaestuL, de Miguel-diezJ. Readmission due to exacerbation of COPD: associated factors. Lung. 2018;196(2):185–193. doi:10.1007/s00408-018-0093-y29445935
   PubMed Web of Science ®Google Scholar
• AryalS, Diaz-GuzmanE, ManninoDM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–218. doi:10.1016/j.trsl.2013.04.00323684710
   PubMed Web of Science ®Google Scholar
• WhitneyP, ChuangEJ. Relationship between insurance and 30-day readmission rates in patients 65 years and older discharged from an acute care hospital with hospice services. J Hosp Med. 2016;11(10):688–693. doi:10.1002/jhm.v11.1027222206
   PubMed Web of Science ®Google Scholar
• Villalobos DintransP, BossertTJ, SherryJ, KrukME. A synthesis of implementation science frameworks and application to global health gaps. Global Health Res Policy. 2019;4:25. doi:10.1186/s41256-019-0115-1
   PubMedGoogle Scholar